Optimizing outcome of charles procedure for chronic lower extremity lymphoedema.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21042186.
- Also identified by DOI 10.1097/SAP.0b013e3181d6e45e.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Charles procedure for late-stage lower limb lymphoedema (LLL) is often criticized for its unpredictable and poor results. We have adopted a systematic approach to optimize outcome of patients treated with this excisional surgery. From June 2004 to March 2009 we performed the Charles procedure on 1 lower limb of 19 women and 8 men with late-stage LLL. Mean age and follow-up was 48 (range, 16.5-77.8) years and 21.6 (range, 1.5-48) months, respectively. Average inpatient stay was 27 (range, 11-54) days. After discharge, 16 (59.3%) patients underwent further minor surgery. The most frequent complication was a single, short episode of cellulitis, affecting 5 (18.5%) patients. Self-reported mobility was either the same or improved at 6 months, and appearance of their limbs satisfactory. The Charles procedure is an effective treatment for selected patients and by applying our systematic approach, a positive outcome can be achieved.
Medical subject headings
- Leg
- Lymphedema
- Plastic Surgery Procedures
- Skin Transplantation
- Surgical Flaps